1. Home
  2. LGVN vs UONEK Comparison

LGVN vs UONEK Comparison

Compare LGVN & UONEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Longeveron Inc.

LGVN

Longeveron Inc.

HOLD

Current Price

$6.83

Market Cap

25.9M

Sector

Health Care

ML Signal

HOLD

Logo Urban One Inc. Class D

UONEK

Urban One Inc. Class D

N/A

Current Price

$4.36

Market Cap

22.9M

ML Signal

N/A

Company Overview

Basic Information
Metric
LGVN
UONEK
Founded
2014
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Broadcasting
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
25.9M
22.9M
IPO Year
2021
1999

Fundamental Metrics

Financial Performance
Metric
LGVN
UONEK
Price
$6.83
$4.36
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
595.3K
9.2K
Earning Date
05-08-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
50.76
N/A
EPS
N/A
N/A
Revenue
$709,000.00
$439,098,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$10.81
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.48
$0.45
52 Week High
$1.23
$9.38

Technical Indicators

Market Signals
Indicator
LGVN
UONEK
Relative Strength Index (RSI) 96.06 42.78
Support Level $0.60 $4.26
Resistance Level N/A $5.05
Average True Range (ATR) 0.12 0.22
MACD 0.38 -0.08
Stochastic Oscillator 93.29 15.79

Price Performance

Historical Comparison
LGVN
UONEK

About LGVN Longeveron Inc.

Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.

About UONEK Urban One Inc. Class D

Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.

Share on Social Networks: